Transaction | Address | Amount |
---|---|---|
0x040e...e5c1e3
|
0x3856...923bca
|
-
0.003585940437827678 ETH
·
5.84 USD
|
0x040e...e5c1e3
|
the-void |
+
0.003585940437827678 ETH
·
5.84 USD
|
0x040e...e5c1e3
|
0x3856...923bca
|
-
0 ETH
·
0.00 USD
|
0x040e...e5c1e3
|
0x0000...0f594e
|
+
0 ETH
·
0.00 USD
|
0xc658...c6e7e4
|
0x6182...d9a77c
|
-
0.004336067713681998 ETH
·
7.06 USD
|
0xc658...c6e7e4
|
the-void |
+
0.004336067713681998 ETH
·
7.06 USD
|
0xc658...c6e7e4
|
0x6182...d9a77c
|
-
0.002036292286318002 ETH
·
3.31 USD
|
0xc658...c6e7e4
|
0x690b...fac990
|
+
0.002036292286318002 ETH
·
3.31 USD
|
0xc658...c6e7e4
|
0x6182...d9a77c
|
-
0.2 ETH
·
325.80 USD
|
0xc658...c6e7e4
|
0x7a25...f2488d
|
+
0.2 ETH
·
325.80 USD
|
BitMine opts for a $1 billion share repurchase plan, prioritizing buybacks over increasing its Ethereum holdings, as its stock trades below net asset value.
Abraxas Capital faces $100M in unrealized losses on $800M crypto shorts amidst a bullish market.
180 Life Sciences pivots to crypto with a $425 million investment in Ethereum, aiming to become "ETHZilla" and create the largest corporate ETH treasury.